OppenheimerFunds’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

OppenheimerFunds’s Portfolio NXGN Stock Details NXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$292K	Buy	17,335 +878	+5%	+$15.2K	﹤0.01%	1560
2018 Q4	$249K	Buy	16,457 +249	+2%	+$4.27K	﹤0.01%	1653
2018 Q3	$325K	Sell	16,208 -2,834	-15%	-$60.1K	﹤0.01%	1628
2018 Q2	$371K	Sell	19,042 -5,360	-22%	-$84.7K	﹤0.01%	1542
2018 Q1	$333K	Sell	24,402 -2,224	-8%	-$29.3K	﹤0.01%	1556
2017 Q4	$361K	Buy	26,626 +3,721	+16%	+$53.4K	﹤0.01%	1629
2017 Q3	$361K	Sell	22,905 -542	-2%	-$8.75K	﹤0.01%	1652
2017 Q2	$404K	Sell	23,447 -2,319	-9%	-$35.2K	﹤0.01%	1606
2017 Q1	$392K	Buy	25,766 +2,469	+11%	+$36.4K	﹤0.01%	1606
2016 Q4	$306K	Buy	23,297 +3,082	+15%	+$39.5K	﹤0.01%	1589
2016 Q3	$229K	Buy	20,215 +962	+5%	+$11.6K	﹤0.01%	1604
2016 Q2	$229K	Buy	19,253 +4,860	+34%	+$65.4K	﹤0.01%	1567
2016 Q1	$219K	Sell	14,393 -681	-5%	-$10.3K	﹤0.01%	1571
2015 Q4	$243K	Buy	+15,074	New	+$220K	﹤0.01%	1596

Other funds holding NXGN

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OppenheimerFunds's NXGN Position: Q1 2019 in Review

OppenheimerFunds increased its NextGen Healthcare, Inc. Common Stock (NXGN) stake by 5.3% in Q1 2019, buying an estimated $15.2K and bringing the position to 17,335 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #1560.

OppenheimerFunds first reported a position in NXGN in Q4 2015 and has held it in 14 quarters since. The position peaked at $404K in Q2 2017. 174 funds tracked by Wall St. Rank hold NXGN as of Q1 2019.

OppenheimerFunds held 17,335 shares of NextGen Healthcare, Inc. Common Stock worth $292K as of Q1 2019.
OppenheimerFunds bought 878 NextGen Healthcare, Inc. Common Stock shares in Q1 2019, an estimated $15.2K.
NextGen Healthcare, Inc. Common Stock made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1560 holding.
OppenheimerFunds first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2015 and has held it in 14 quarters since.
OppenheimerFunds's NextGen Healthcare, Inc. Common Stock position peaked at $404K in Q2 2017.
174 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.